维普中文期刊产品整合服务
220篇 您的检索式:作者名="Davison P"
    题名 作者 年代 出处 被引量
1Prospective randomized controlled trial evaluating cap-assisted colonoscopy vs standard colonoscopy显示文摘AIM: To study the significance of cap-fitted colonoscopy in improving cecal intubation time and polyp detection rate. METHODS: This study was a prospective randomized controlled trial conducted from March 2008 to February 2009 in a tertiary referral hospital at Sydney. The primary end point was cecal intubation time and the secondary endpoint was polyp detection rate. Consecutive cases of total colonoscopy over a 1-year period were recruited. Randomization into either standard colonoscopy (SC) or cap-assisted colonoscopy (CAC) was performed after consent was obtained. For cases randomized to CAC, one of the three sizes of cap was used: D-201-15004 (with a diameter of 15.3 mm), D-201-14304 (14.6 mm) and D-201-12704 (13.0 mm). All of these caps were produced by Olympus Medical Systems, Japan. Independent predictors for faster cecal time and better polyp detection rate were also determined from this study. RESULTS: There were 200 cases in each group. There was no signif icant difference in terms of demographic characteristics between the two groups. CAC, when compared to the SC group, had no signif icant difference in terms of cecal intubation rate (96.0% vs 97.0%, P = 0.40) and time (9.94 ± 7.05 min vs 10.34 ± 6.82 min, P = 0.21), or polyp detection rate (32.8% vs 31.3%, P = 0.75). On the subgroup analysis, there was no significant difference in terms of cecal intubation time by trainees (88.1% vs 84.8%, P = 0.40), ileal intubation rate (82.5% vs 79.0%, P = 0.38) or total colonoscopy time (23.24 ± 13.95 min vs 22.56 ± 9.94 min, P = 0.88). On multivariate analysis, the independent determinants of faster cecal time were consultant-performed procedures (P < 0.001), male patients (P < 0.001), non-usage of hyoscine (P < 0.001) and better bowel preparation (P = 0.01). The determinants of better polyp detection rate were older age (P < 0.001), no history of previous abdominal surgery (P = 0.04), patients not having esophagogastroduodenoscopy in the same setting (P = 0.003), trainee-performed procedures (P = 0.01), usage of hyoscine (P = 0.01) and procedures performed for polyp follow-up (P = 0.01). The limitations of the study were that it was a single-center experience, no blinding was possible, and there were a large number of endoscopists. CONCLUSION: CAC did not signif icantly different from SC in term of cecal intubation time and polyp detection rate.Hoi-Poh Tee Crispin Corte Hamdan Al-Ghamdi Emilia Prakoso John Darke Raman Chettiar Wassim Rahman Scott Davison Sean P Griffin Warwick S Selby Arthur J Kaffes 2010World Journal of Gastroenterology2010,16,31:10
2Residual renal function in peritoneal dialysis with failed allograft and minimum immunosuppression显示文摘Immunosuppression(IS) is often withdrawn in patients with end stage renal disease secondary to a failed renal allograft, and this can lead to an accelerated loss of residual renal function(RRF). As maintenance of RRF appears to provide a survival benefit to peritoneal dialysis(PD) patients, it is not clear whether this benefit of maintaining RRF in failed allograft patients returning to PD outweigh the risks of maintaining IS. A 49 year-old Caucasian male developed progressive allograft failure nine years after living-donor renal transplantation. Hemodialysis was initiated via tunneled dialysis catheter(TDC) and IS was gradually withdrawn. Two weeksafter IS withdrawal he developed a febrile illness, which necessitate removal of the TDC and conversion to PD. He was maintained on small dose of tacrolimus(1 mg/d) and prednisone(5 mg/d). Currently(1 year later) he is doing exceedingly well on cycler-assisted PD. Residual urine output ranges between 600-1200 m L/d. Total weekly Kt/V achieved 1.82. RRF remained well preserved in this patient with failed renal allograft with minimal immunosuppressive therapy. This strategy will need further study in well-defined cohorts of PD patients with failed allografts and residual RRF to determine efficacy and safety.Nadear Elmahi éva Csongrádi Kenneth Kokko Jack R Lewin Jamie Davison Tibor Fülp 2013World Journal of Transplantation2013,3,2:5
3System Studies on CO2 Abatement From Power Plant 显示文摘Goldthorpe S H Cross P J I Davison J E 1992Energy Convers Mgmt1992,33,58:1
4Stability of interfacial waves in aluminum reduction cell显示文摘L1NDSAY R I DAVISON P A 1998Journal of Fluid Mechanics1998,362,:1
5The family Parvoviridae显示文摘Cotmore S F Agbandje-McKenna M Chiorini J A Mukha D V Pintel D J Qiu J Soderlund-Venermo M Tattersall P Tijssen P Gatherer D Davison A J 2014Arch Virol2014,159,5:1
6Rotational Stiffness Characteristics of Steel Beam-to-column Connections显示文摘Davison J B Kirby P A Nethercot D A 1987J of Construct Steel Research1987,,8:1
7Tissue expander infections in children:look beyond the expander pocket显示文摘 DAVISON S P MANDERS E K 1999Ann Plast Surg1999,43,5:1
8Stereotactic radiosurgery:the patient's experience显示文摘Menkes D B Davison M P Costello S A 0,,11:1
9Overexpression of beta-carotene hydroxylase enhances stress tolerance in Arabidopsis 显示文摘Davison P A Hunter C N Horton P 2002Nature2002,418,:1
10The third-person effect in communieation显示文摘W P Davison 1983Public Opinion Quarterly1983,47,:1
11Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates显示文摘Di Giovanna NIP Chu P Davison TL 2002Cancer Res2002,62,22:1
12Succinic acid adsorption from fermentation broth and regeneration显示文摘DAVISON B H NGHIEM N P RICHARDSON G L Applied Biochemistry and Biotechnology-Part A Enzyme Engineering and Biotechnology0,114,123:1
13Experimental analysis and modeling of limit cycles in a dynamic wind tunnel rig显示文摘DAVISON P M LOWENBERG M H 2003Journal of Aircraft2003,40,4:1
14Production of succinic acid by Anaerobiospirillum succiniciproducens显示文摘Nghiem N P Davison B H Suttle B E 1997Applied Biochemistry andBiotechnology1997,63,5:1
15Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ:clinicopathological correlates显示文摘Digiovanna MP Chu P Davison TL 2002Cancer Res2002,62,22:1
16Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease显示文摘KAISER P UNDERWOOD G DAVISON F 2002J Virol2002,77,1:1
17Kinetics of metal exchange be- tween solids and solutions in sediments and soils interpreted from DGT measured fluxes显示文摘Harper M P Davison W Zhang H 1998Geochimicaet Cosmochimica Acta1998,62,16:1
18Production of succinic acid by Anaerobiospirillum succiniciproducens显示文摘Nghiem N P Davison B H Suttle B E 1997Appl Biochem Biotech1997,63,5:1
19Rotational stiffness characteristics of steel beam-to-column connections 显示文摘Davison J B Kirby P A Nethercot D A 1987Journal of Constructional Steel Research1987,8,1:1
20Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography显示文摘Boyd SK Davison P Muller R 0,,:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费